Skip to content
cefovecin

Structure via PubChem · Public domain (PubChem)

EntityQ409743· pop 9· linked from 188 articles

Cefovecin (INN) is an antibiotic of the cephalosporin class, licensed for the treatment of skin infections in cats and dogs. It is marketed by Zoetis under the trade name Convenia. It is used to treat skin infections caused by Pasteurella multocida in cats, and Staphylococcus intermedius and Streptococcus canis in dogs. The advantage of using a long-acting injectable antibiotic is that, unlike in daily administration, doses cannot be missed. Missed doses may allow partially resistant microbes to recover. The disadvantage is the presence of subtherapeutic concentrations in the weeks after the r

Chemical data

Formula
C17H19N5O6S2
Molecular weight
453.5 g/mol
IUPAC name
(7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-3-[(2S)-oxolan-2-yl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
SMILES
CO/N=C(/C1=CSC(=N1)N)\C(=O)N[C@H]2C3N(C2=O)C(=C(CS3)[C@@H]4CCCO4)C(=O)O
InChIKey
ZJGQFXVQDVCVOK-LTRDADOWSA-N
XLogP
-0.9
Polar surface area
210 Ų
H-bond donors
3
H-bond acceptors
11
Formal charge
0

via PubChem

Drug data · ChEMBL

Molecule type
Small molecule

via ChEMBL · EBI

Wikidata facts

Mass
453.077675328
Show 5 more facts
chemical formula
C₁₇H₁₉N₅O₆S₂
canonical SMILES
CON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C4CCCO4)C(=O)O
isomeric SMILES
CO\N=C(/C(=O)N[C@H]1[C@H]2SCC([C@@H]3CCCO3)=C(N2C1=O)C(O)=O)C4=CSC(N)=N4
NCI Thesaurus ID
C76035
Commons category
Cefovecin
Sources (2)

via Wikidata · CC0

~3 min read

Encyclopedic overview

9 sections
Contents
  • Medical uses
  • Contraindications
  • Adverse effects
  • Pharmacology
  • Mechanism of action
  • Pharmacokinetics
  • Society and culture
  • References
  • External links

Cefovecin (INN) is an antibiotic of the cephalosporin class, licensed for the treatment of skin infections in cats and dogs. It is marketed by Zoetis under the trade name Convenia. It is used to treat skin infections caused by Pasteurella multocida in cats, and Staphylococcus intermedius and Streptococcus canis in dogs. The advantage of using a long-acting injectable antibiotic is that, unlike in daily administration, doses cannot be missed. Missed doses may allow partially resistant microbes to recover. The disadvantage is the presence of subtherapeutic concentrations in the weeks after the resolution of infections. This is associated with the development of resistance in microbes. It should not be used in pregnant or lactating animals or in animals with a history of allergies to penicillin or cephalosporin drugs.

==Medical uses==

Excerpted from Wikipedia’s “cefovecin” article, available under the CC BY-SA 4.0 licence.

Available in 8 languages

via Wikidata sitelinks · CC0